ATE277641T1 - Verfahren zur selektion eines salzes zur herstellung eines inklusionskomplexes - Google Patents
Verfahren zur selektion eines salzes zur herstellung eines inklusionskomplexesInfo
- Publication number
- ATE277641T1 ATE277641T1 AT97302821T AT97302821T ATE277641T1 AT E277641 T1 ATE277641 T1 AT E277641T1 AT 97302821 T AT97302821 T AT 97302821T AT 97302821 T AT97302821 T AT 97302821T AT E277641 T1 ATE277641 T1 AT E277641T1
- Authority
- AT
- Austria
- Prior art keywords
- salt
- solubility
- selecting
- producing
- inclusion complex
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Seasonings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1686696P | 1996-05-07 | 1996-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE277641T1 true ATE277641T1 (de) | 2004-10-15 |
Family
ID=21779426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97302821T ATE277641T1 (de) | 1996-05-07 | 1997-04-24 | Verfahren zur selektion eines salzes zur herstellung eines inklusionskomplexes |
Country Status (9)
Country | Link |
---|---|
US (1) | US20010007862A1 (de) |
EP (1) | EP0811386B1 (de) |
JP (2) | JP3007312B2 (de) |
AT (1) | ATE277641T1 (de) |
CA (1) | CA2204451C (de) |
DE (1) | DE69730902T2 (de) |
DK (1) | DK0811386T3 (de) |
ES (1) | ES2224205T3 (de) |
PT (1) | PT811386E (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
IL127497A (en) * | 1997-12-18 | 2002-07-25 | Pfizer Prod Inc | Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders |
EP1346224B1 (de) * | 2000-10-19 | 2017-03-01 | Mycartis N.V. | Verfahren zur manipulation von mikroträgern zu identifizierungszwecken |
US6884885B2 (en) | 2000-12-21 | 2005-04-26 | Cerestar Holding B.V. | Production of cyclodextrin complexes |
DE10215942A1 (de) * | 2002-04-11 | 2003-10-23 | Bayer Ag | Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat |
EP1562546A1 (de) * | 2002-10-25 | 2005-08-17 | Pfizer Products Inc. | Depotformulierungen arylheterozyklischer wirkstoffen in form von suspensionen |
US20050266398A1 (en) * | 2004-06-01 | 2005-12-01 | Peter Lea | Method and device for rapid detection and quantitation of macro and micro matrices |
US20080300173A1 (en) * | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
CA2475240A1 (en) * | 2004-07-20 | 2006-01-20 | Biophys, Inc. | Method and device to measure dynamic internal calibration true dose response curves |
CA2475191A1 (en) * | 2004-07-20 | 2006-01-20 | Biophys, Inc. | System and method for rapid reading of macro and micro matrices |
CA2475456A1 (en) | 2004-07-20 | 2006-01-20 | Biophys, Inc. | Method and device to optimize analyte and antibody substrate binding by least energy adsorption |
CA2593497A1 (en) * | 2005-02-11 | 2006-08-17 | Judith Aronhime | Amorphous ziprasidone mesylate |
EP1742943A1 (de) * | 2005-02-11 | 2007-01-17 | Teva Pharmaceutical Industries Ltd | Verfahren zur bereidung von ziprasidon mesylat |
EP1858891A2 (de) * | 2005-03-14 | 2007-11-28 | Teva Pharmaceutical Industries Ltd. | Kristalline formen von ziprasidonmesylat |
WO2006099452A1 (en) * | 2005-03-14 | 2006-09-21 | Teva Pharmaceutical Industries Ltd. | Anhydrous ziprasidone mesylate and a process for its preparation |
CA2569971A1 (en) * | 2006-12-04 | 2008-06-04 | Umedik Inc. | Method for double-dip substrate spin optimization of coated micro array supports |
WO2011080749A1 (en) * | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Process for purification of ziprasidone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
UA57734C2 (uk) * | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
-
1997
- 1997-04-24 AT AT97302821T patent/ATE277641T1/de not_active IP Right Cessation
- 1997-04-24 ES ES97302821T patent/ES2224205T3/es not_active Expired - Lifetime
- 1997-04-24 PT PT97302821T patent/PT811386E/pt unknown
- 1997-04-24 EP EP97302821A patent/EP0811386B1/de not_active Expired - Lifetime
- 1997-04-24 DE DE69730902T patent/DE69730902T2/de not_active Expired - Fee Related
- 1997-04-24 DK DK97302821T patent/DK0811386T3/da active
- 1997-05-02 US US08/850,353 patent/US20010007862A1/en not_active Abandoned
- 1997-05-05 CA CA002204451A patent/CA2204451C/en not_active Expired - Fee Related
- 1997-05-06 JP JP9115720A patent/JP3007312B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-13 JP JP11291178A patent/JP2000086539A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP3007312B2 (ja) | 2000-02-07 |
ES2224205T3 (es) | 2005-03-01 |
US20010007862A1 (en) | 2001-07-12 |
EP0811386B1 (de) | 2004-09-29 |
DE69730902D1 (de) | 2004-11-04 |
EP0811386A2 (de) | 1997-12-10 |
JP2000086539A (ja) | 2000-03-28 |
MX9703304A (es) | 1998-05-31 |
DE69730902T2 (de) | 2006-02-23 |
EP0811386A3 (de) | 1999-02-10 |
PT811386E (pt) | 2004-12-31 |
CA2204451C (en) | 2004-06-29 |
CA2204451A1 (en) | 1997-11-07 |
DK0811386T3 (da) | 2005-01-03 |
JPH1059871A (ja) | 1998-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE277641T1 (de) | Verfahren zur selektion eines salzes zur herstellung eines inklusionskomplexes | |
DE69227056D1 (de) | Verfahren zur Fehleranalyse unter Verwendung eines Elektronenstrahles | |
DE58903372D1 (de) | Verfahren zur herstellung eines 1-olefinpolymers. | |
DE69707145D1 (de) | Verfahren zur herstellung eines aldehyds | |
DE69435092D1 (de) | Verfahren zur Herstellung einer optischen Kompensationsfolie | |
DE69426201D1 (de) | Verfahren zur herstellung eines antitranspirantstifter | |
DE60042601D1 (de) | Verfahren zur regelung des nullpunktpotentials eines wandlers mit nullpunktbegrenzung | |
DE69003090D1 (de) | Kalibrierungsverfahren eines dreidimensionalen formerfassungssystems und system zur durchführung des genannten verfahrens. | |
DE3584179D1 (de) | Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i. | |
DE69101432D1 (de) | Verfahren zur meeresseismischendatenerfassung. | |
DE3686842D1 (de) | Verfahren zur herstellung eines optischen transmissionsmediums. | |
DE69233414D1 (de) | Verfahren zur bestimmung eines alternativen leitweges | |
DE50214846D1 (de) | Verfahren zur Erkennung und Verfolgung von Objekten | |
DE69108627D1 (de) | Verfahren zum Herstellen eines amorphen, magnetischen Films. | |
DE69108938D1 (de) | Verfahren zur Herstellung eines Feldeffekttransistors mit einer LDD-Struktur. | |
DE69422557D1 (de) | Verfahren zur herstellung chromhaltiger rostfreier stahlbänder mit ausgezeichneter zähigkeit | |
DE69215983D1 (de) | Verfahren zur Messung der Konzentration eines Immuno-Reaktanden unter Verwendung von Elektrochemilumineszenz | |
DE69819857D1 (de) | Verfahren zur herstellung eines optischen leiters | |
DE69318380D1 (de) | Verfahren zur Herstellung eines Orientierungsfilmes | |
DE58904509D1 (de) | Verfahren zur herstellung eines elastomerhaltigen vinylchloridpfropfcopolymerisats. | |
DE69101150D1 (de) | Verfahren zum Lokalisieren eines Fehlers. | |
DE69213778D1 (de) | Verfahren zur Herstellung eines opto-elektronischen Bauteils | |
DE69029290D1 (de) | Verfahren zur herstellung eines 2,2-difluorpropans | |
ATE192628T1 (de) | Verfahren zur herstellung eines einbügelbaren einlagestoffs | |
DE68907209D1 (de) | Verfahren zur herstellung eines supraleitfaehigen duennfilmes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0811386 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |